3p25 Aneusomy in Follicular Thyroid Neoplasms: A Report of Three Cases with Review of Literature

3p25 aneusomy in follicular thyroid neoplasms

Prof. Dr. Sharifah Noor Akmal, Department of Pathology, Faculty of Medicine, Universiti Kebangsaan Malaysia, Jalan Yaakob Latif, Bandar Tun Razak, 56000 Cheras, Kuala Lumpur. Tel: 603-9145 5372. Fax: 603-9145 6676. Email: sharifah@ppukm.ukm.edu.my

Alcaraz, A., Takahashi, S., Brown, J., Herath, J.F., Bergstralh, E.J., Larson-Keller, J.J., Lieber, M.M. & Jenkins, R.B. 1994. Aneuploidy and aneusomy of chromosome 7 detected by fluorescence in situ hybridization are markers of poor prognosis in prostate cancer. Cancer Res 54:3998-4002. Banito, A., Pinto, A.E., Espadinha, C., Marques, A.R. & Leite, V. 2007. Aneuploidy and RAS mutations are mutually exclusive events in the development of well-differentiated thyroid follicular tumours. Clin Endocrinol 67:706–711. Barril, N., Carvalho-Sales, A.B. & Tajara, E.H. 2000. Detection of numerical chromosome anomalies in interphase cells of benign and malignant thyroid lesions using fluorescence in situ hybridization. Cancer Genet Cytogenet 117:50-56. Belge, G., Roque, L., Soares, J., Bruckmann, S., Thode, B., Fonseca, E., Clode, A., Bartnitzke, S., Castedo, S. & Bullerdiek, J. 1998. Cytogenetic Investigations of 340 Thyroid Hyperplasias and Adenomas Revealing Correlations between Cytogenetic Findings and Histology. Cancer Genet Cytogenet 101:42-48. Boveri, T. 1964. On multipolar mitosis as a means of analysis of the cell nucleus (originally published 1902). In Foundations of Experimental Embryology. Edited by Willier, B.H. & Oppenheimer, J.M. Englewood Cliffs, NJ: Prentice-Hall;74–97. Carlson, J.A., Healy, K., Tran, T.A., Malfetano, J., Wilson, V.L., Rohwedder, A. & Ross, J.S. 2000. Chromosome 17 aneusomy detected by fluorescence in situ hybridization in vulvar squamous cell carcinomas and synchronous vulvar skin. Am J Pathol 157(3):973-983. Cheung, L., Messina, M., Gill, A., Clarkson, A., Learoyd, D., Delbridge, L., Wentworth, J., Philips, J., Clifton-Bligh, R. & Robinson, B.G. 2003. Detection of the PAX8-PPARγ Fusion Oncogene in Both Follicular Thyroid Carcinomas and Adenomas. J Clin Endocrinol Metab 88(1):354-357. Chia, W.K., Sharifah, N.A., Reena, R.M.Z., Zubaidah, Z., Clarence-Ko, C.H., Rohaizak, M., Naqiyah, I., Srijit, D., Nor Hisham, A., Asmiati, A. & Rafie, M.K. 2010. Fluorescence in situ hybridization analysis using PAX8- and PPARG-specific probes reveals the presence of PAX8-PPARG translocation and 3p25 aneusomy in follicular thyroid neoplasms. Cancer Genet Cytogenet 196:7-13. Chiappetta, G., Toti, P., Cetta, F., Giuliano, A., Pentimalli, F., Amendola, I., Lazzi, S., Monaco, M., Mazzuchelli, L., Tosi, P., Santoro, M. & Fusco, A. 2002. The RET/PTC oncogene is frequently activated in oncocytic thyroid tumors (Hurthle cell adenomas and carcinomas), but not in oncocytic hyperplastic lesions. J Clin Endocrinol Metab 87:4715-4721. Criado, B., Barros, A., Suijkerbuijk, R.F., Weghuis, D.O., Seruca, R., Fonseca, E. & Castedo, S. 1995. Detection of numerical alterations for chromosomes 7 and 12 in benign thyroid lesions by in situ hybridization. Am J Pathol 147:136-144. Dettori, T., Frau, D.V., Lai, M.L., Mariotti, S., Uccheddu, A., Daniele, G.M., Tallini, G., Faa, G. & Vanni, R. 2003. Aneuploidy in oncocytic lesions of the thyroid gland: diffuse accumulation of mitochondria within the cell is associated with trisomy 7 and progressive numerical chromosomal alterations. Genes Chromosomes Cancer 38:22-31. Dwight, T., Thoppe, S.R., Foukakis, T., Lui, W.O., Wallin, G., Hoog, A., Frisk, T., Larsson, C. & Zedenius, J. 2003. Involvement of the PAX8/peroxisome proliferator-activated receptor gamma rearrangement in follicular thyroid tumors. J Clin Endocrinol Metab 88:4440-4445. Espadinha, C., Pinto, A.E. & Leite, V. 2009. Underexpression of PPARÁ is associated with aneuploidy and lower differentiation of thyroid tumours of follicular origin. Oncology Reports 22:907-913. French, C.A., Alexander, E.K., Cibas, E.S., Nose, V., Laguette, J., Faquin, W., Garber, J., Moore, Jr.F., Fletcher, J.A., Larsen, P.R. & Kroll, T.G. 2003. Genetic and biological subgroups of low-stage follicular thyroid cancer. Am J Pathol 162(4):1053-1060. Grant, C.S., Hay, I.D., Ryan, J.J., Bergstralh, E.J., Rainwater, L.M. & Goellner, J.R. 1990. Diagnostic and prognostic utility of flow cytometric DNA measurements in follicular thyroid tumors. World J Surg 14:283–289. Hansemann, D. 1890. Ueber asymmetrische Zelltheilung in Epithelkrebsen und deren biologische Bedeutung. Virchows Arch. A Pathol. Anat. Histol 119:299–326. Hemmer, S., Wasenius, V.M., Knuutila, S., Joensuu, H. & Franssila, K. 1998. Comparison of benign and malignant follicular thyroid tumours by comparative genomic hybridization. Brit J Cancer 78:1012–1017. Hibi, Y., Nagaya, T., Kambe, F., Imai, T., Funahashi, H., Nakao, A. & Seo, H. 2004. Is thyroid follicular cancer in Japanese caused by a specific t(2;3)(q13; p25) translocation generating Pax8-PPARg fusion mRNA? Endocrine Journal 51:361-366. Isaka, T., Nestor, A.L., Takada, T. & Allison, D.C. 2003. Chromosomal variations within aneuploid cancer lines. J Histochem Cytochem 51(10):1343-1353. Johannessen, J.V., Sobrinho-Simões, M. & Tangen, K.O. 1982. The diagnostic value of flow cytometric DNA measurements in selected disorders of the human thyroid. Am J Clin Pathol 77:20–25. Jonsson, S., Varella-Garcia, M., Miller, Y.E., Wolf, H.J., Byers, T., Braudrick, S., Kiatsimkul, P., Lewis, M., Kennedy, T.C., Keith, R.L., Bjornsson, J., McWilliams, A., Lam, S., Hirsch, F.R. & Franklin, W.A. 2008. Chromosomal Aneusomy in Bronchial High-Grade Lesions Is Associated with Invasive Lung Cancer. Am J Respir Crit Care Med 177:342–347. Koenig, R.J. 2010. Detection of the PAX8-PPARγ Fusion Protein in Thyroid Tumors. Clin Chem 56(3):331-333 Kroll, T.G., Sarraf, P., Pecciarini, L., Chen, C.J., Elisabetta, M., Spiegelman, B.M. & Fletcher, J.A. 2000. PAX8-PPARγ1 Fusion Oncogene in Human Thyroid Carcinoma. Science 289:1357-1360. Kroll, T.G. 2004. Molecular Events in Follicular Thyroid Tumors. In Molecular Basis of Thyroid Cancer. Edited by Farid NR. Boston: Kluwer Academic Publishers; 85-105. Lengauer, C., Kinzler, K.W. & Vogelstein, B. 1998. Genetic instabilities in human cancers. Nature 396:643-649. Lui, W.O., Foukakis, T., Liden, J., Thoppe, S.R., Dwight, T., Hoog, A., Zedenius, J., Wallin, G., Reimers, M. & Larsson, C. 2004. Expression profiling reveals a distinct transcription signature in follicular thyroid carcinomas with a PAX8-PPARγ fusion oncogene. Oncogene 1-10. Marques, A.R., Espadinha, C., Frias, M.J., Roque, L., Catarino, A.L., Sobrinho, L.G. & Leite, V. 2004. Underexpression of peroxisome proliferator-activated receptor (PPAR)g in PAX8/PPARg-negative thyroid tumours. Brit J Cancer 91:732-738. Nakamura, H., Saji, H., Idiris, A., Kawasaki, N., Hosaka, M., Ogata, A., Saijo, T. & Kato, H. 2003. Chromosomal Instability Detected by Fluorescence in Situ Hybridization in Surgical Specimens of Non-Small Cell Lung Cancer Is Associated with Poor Survival. Clin Cancer Res 9:2294-2299. Nikiforova, M.N., Biddinger, P.W., Caudill, C.M., Kroll, T.G. & Nikiforov, Y.E. 2002. PAX8-PPARgamma rearrangement in thyroid tumors: RT-PCR and immunohistochemical analyses. Am J Surg Pathol 26:1016-1023. Nikiforova, M.N., Lynch, R.A., Biddinger, P.W., Alexander, E.K., Dorn II, G.W., Tallini, G., Kroll, T.G. & Nikiforov, Y.E. 2003. RAS point mutations and PAX8-PPAR gamma rearrangement in thyroid tumors: evidence for distinct molecular pathways in thyroid follicular carcinoma. J Clin Endocrinol Metab 88:2318-2326. Nikiforov, Y.E. 2010. Recent Developments in the Molecular Biology of the Thyroid. In Lloyd RV (ed). Endocrine Pathology. Springer: New York; 237-260 pp Ouyang, B., Knauf, J.A., Ain, K., Nacev, B. & Fagin, J.A. 2002. Mechanisms of aneuploidy in thyroid cancer cell lines and tissues: evidence for mitotic checkpoint dysfunction without mutations in BUB1 and BUBR1. Clin Endocrinol 56:341-350. Oyama, T., Vickery, A.L.Jr., Preffer, F.I. & Colvin, R.B. 1994. A comparative study of flow cytometry and histopathologic findings in thyroid follicular carcinomas and adenomas. Hum Pathol 25:271–275 Panani, A.D., Babanaraki, A., Malianga, E. & Roussos, C. 2004. Numerical aberrations of chromosomes 9 and 11 detected by FISH in Greek bladder cancer patients. Anticancer Res 24:3857-3862. Pihan, G. & Doxsey, S.J. 2003. Mutations and aneuploidy: Co-conspirators in cancer? Cancer Cell 4:89-94. Pierotti, M.A. 2001. Chromosomal rearrangements in thyroid carcinomas: a recombination or death dilemma. Cancer Lett 166:1–7 Placer, J., Espinet, B., Salido, M., Sole, F. & Gelabert-Mas, A. 2005. Correlation between histologic findings and cytogenetic abnormalities in bladder carcinoma: a FISH story. Urology 65:913-918. Roque, L., Serpa, A., Clode, A., Castedo, S. & Soares, J. 1999. Significance of trisomy 7 and 12 in thyroid lesions with follicular differentiation: a cytogenetic and in situ hybridization study. Lab Invest 79:369–378. Sahin, M., Allard, B.L., Yates, M., Powell, J.G., Wang, X-L., Hay, I.D., Zhao, Y., Goellner, J.R., Sebo, T.J., Grebe, S.K.G., Eberhardt, N.L. & McIver, B. 2005. PPARγ Staining as a Surrogate for PAX8/PPARγ Fusion Oncogene Expression in Follicular Neoplasms: Clinicopathological Correlation and Histopathological Diagnostic Value. J Clin Endocrinol Metab 90(1):463-468. Sobrinho-Simões, M., Asa, S.L., Kroll, T.G., Nikiforov, Y., DeLellis, R., Farid, P., Kitamura, Y., Noguchi, S.U., Eng, C., Harach, H.R., Williams, E.D., Schneider, A.B., Fagin, J.A., Ghossein, R.A., Mazzaferri, E.L., Lloyd, R.V., LiVolsi, V., Chan, J.K.C., Baloch, Z. & Clark, O.H. 2004. Follicular Carcinoma. In Pathology and Genetics of Tumours of Endocrine Organs. Edited by DeLellis R, Lloyd R, Heitz P, Eng C. Lyon, IARC. Stojadinovic, A., Hoos, A., Ghossein, R.A., Urist, M.J., Leung, D.H., Spiro, R.H., Shah, J.P., Brennan, M.F., Singh, B. & Shaha, A.R. 2002. Hurthle cell carcinoma: a 60-year experience. Ann Surg Onco. 9:197-203. Tallini, G., Santoro, M., Helie, M., Carlomagno, F., Salvatore, G., Chiappetta, G., Carcangiu, M.L. & Fusco, A. 1998. RET/PTC oncogene activation defines a subset of papillary thyroid carcinomas lacking evidence of progression to poorly differentiated or undifferentiated tumor phenotypes. Clin Cancer Res 4:287–294. Tallini, G., Hsueh, A., Liu, S., Garcia-Rostan, G., Speicher, M.R. & Ward, D.C. 1999. Frequent chromosomal DNA unbalance in thyroid oncocytic (Hurthle cell) neoplasms detected by comparative genomic hybridization. Lab Invest 79:547-555. Upender, M.B., Habermann, J.K., McShane, L.M., Korn, E.L., Barrett, J.C., Difilippantonio, M.J. & Ried, T. 2004. Chromosome Transfer Induced Aneuploidy Results in Complex Dysregulation of the Cellular Transcriptome in Immortalized and Cancer Cells. Cancer Res 64:6941–6949. Wang, S., Saboorian, M.H., Frenkel, E.P., Haley, B.B., Siddiqui, M.T., Gokaslan, S., Hynan, L. & Ashfaq, R. 2002. Aneusomy 17 in Breast Cancer: Its Role in HER-2/neu Protein Expression and Implication for Clinical Assessment of HER-2/neu Status. Mod Pathol 15(2):137-145. Wolman, S.R., Goldman, B., Slovak, M.L., Tangen, C., Persons, D.L. & Wood, D. 2007. Aneusomy for detection of bladder cancer recurrence: a Southwest Oncology Group study. Cancer Genet Cytogenet 176:22-27.